The Conversation

Fri Apr 26

A drug for autism? Potential treatment for Pitt-Hopkins syndrome offers clues

Written by Daniel R. Weinberger, Director of the Lieber Institute for Brain Development and Professor, Departments of Psychiatry, Neurology, Neuroscience and The Institute of Genetic Medicine, Johns Hopkins University

Rylie, age 10, is one of the nearly 1000 children diagnosed with Pitt-Hopkins Syndrome, a rare form of autism. Photo curtesy of Pitt Hopkins Research Foundation. Photo credit: Christa Michelle Photography

In 2019, geeks are cool, and the idea that they might be on the autism spectrum is celebrated. Nowhere is this truer than in Silicon Valley, one...

A drug for autism? Potential treatment for Pitt-Hopkins syndrome offers clues

More Articles ...

Iowa's farmers – and American eaters – need a national discussion on transforming US agriculture

Angkor Wat archaeological digs yield new clues to its civilization's decline

Calling Deion Sanders a sellout ignores the growing role of clout-chasing in college sports

How the media may be making the COVID-19 mental health epidemic worse

SpongeBob's Bikini Bottom is based on a real-life test site for nuclear weapons

Daily DIY sniff checks could catch many cases of COVID-19

Colorado takes a new – and likely more effective – approach to the housing crisis

Wild 'super pigs' from Canada could become a new front in the war on feral hogs

How do grand juries work? Their major role in criminal justice, and why prosecutors are using them to investigate efforts to overturn the 2020 election

Breastfeeding benefits mothers as much as babies, but public health messaging often only tells half of the story